Chordate Medical Holding AB (OSTO:CMH) Inventory-to-Revenue : 3.64 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Chordate Medical Holding AB Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Chordate Medical Holding AB's Average Total Inventories for the quarter that ended in Dec. 2023 was kr1.76 Mil. Chordate Medical Holding AB's Revenue for the three months ended in Dec. 2023 was kr0.48 Mil. Chordate Medical Holding AB's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 3.64.

Chordate Medical Holding AB's Inventory-to-Revenue for the quarter that ended in Dec. 2023 declined from Sep. 2023 (8.24) to Sep. 2023 (3.64)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Chordate Medical Holding AB's Days Inventory for the three months ended in Dec. 2023 was 915.89.

Inventory Turnover measures how fast the company turns over its inventory within a year. Chordate Medical Holding AB's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.10.

Chordate Medical Holding AB Inventory-to-Revenue Historical Data

The historical data trend for Chordate Medical Holding AB's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordate Medical Holding AB Inventory-to-Revenue Chart

Chordate Medical Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory-to-Revenue

Get a 7-Day Free Trial

2.28

1.99

1.08

11.64

1.61

Chordate Medical Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial															62.90	12.85	10.59	8.24	3.64

Competitive Comparison of Chordate Medical Holding AB's Inventory-to-Revenue

For the Medical Devices subindustry, Chordate Medical Holding AB's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordate Medical Holding AB's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Chordate Medical Holding AB's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chordate Medical Holding AB's Inventory-to-Revenue falls into.

Chordate Medical Holding AB Inventory-to-Revenue Calculation

Chordate Medical Holding AB's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (A: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )
=	( (1.366	+	1.771)	/	2 )	/	0.976
=	1.5685					/	0.976
=	1.61

Chordate Medical Holding AB's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (1.742	+	1.771)	/	2 )	/	0.482
=	1.7565					/	0.482
=	3.64

Chordate Medical Holding AB (OSTO:CMH) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Chordate Medical Holding AB's Days Inventory for the three months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	1.7565	/	0.175	*	365 / 4
	=	915.89

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Chordate Medical Holding AB's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	0.175	/	1.7565
	=	0.10

Chordate Medical Holding AB Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chordate Medical Holding AB's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordate Medical Holding AB (OSTO:CMH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chordate Medical Holding AB (OSTO:CMH) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

K1Z:Germany

Address

c/o Regus, Kistagangen 20B, Kista, SWE, 164 40

Website

https://www.chordate.com

Chordate Medical Holding AB is a medical technology company that has developed and patented and CE-marked a new nerve-modulating treatment technology for chronic nasal congestion and chronic migraine. The company sells its products in Selected European markets, Israel and Saudi Arabia. The company's product range is based on the CE-marked treatment units Chordate System S100 and S120 for rhinitis and S220 for migraine, registered for the indications of preventive treatment of chronic migraine and chronic rhinitis and use on patients who are 18 years old or older. The company sells its product system, including treatments, through distributors to clinics and hospitals in its primary markets.

Chordate Medical Holding AB (OSTO:CMH) Headlines

No Headlines